In this month's podcast, Johns Hopkins Kimmel Cancer Director William Nelson discusses screening strategies for all cancers, will active surveillance on some cancer be less expensive in the long run and treatment options for HER2 positive breast cancers.
Program notes:
0:26 Screening for cancers on a population basis
1:26 Find cancers that would never get big and threaten life
2:26 How do we distinguish which cancers are going to be aggressive
3:27 How to appropriately engage patients
4:30 Will active surveillance be less expensive?
5:02 Twenty years of prostate cancer
6:02 Either prostatectomy or surveillance
6:50 HER2 positive breast cancer
7:50 Two drug combination helps
8:50 A bit of a price for treatment
9:35 End